‘Lipitor’ in a great shape, getting away from the second largest one
In the hyperlipidemia field, Lipitor(developed by Pfizer) has remained strong. Its gap with Crestor, the second largest drug, has been expended since the beginning of the year.
Lipitor, which almost got caught, was able to broaden the gap with Crestor(developed by AstraZeneca).
According to the...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
